NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Global Shingles Awareness Survey Highlights Limited Awareness Among Older Indians

Key Findings:

  • A survey of 6,103 adults aged 50-70 across 10 countries, including 752 participants from India, found limited awareness of shingles among older Indians with chronic health conditions.
  • 48% of Indian respondents with chronic conditions have never discussed shingles with a doctor, despite 75% visiting healthcare providers regularly.
  • Awareness was particularly low among patients with diabetes, cardiovascular disease, and COPD.

Impact of Shingles on Older Adults:

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

  • Among those who had developed shingles in the past, 43% of Indian participants reported severe, day-disrupting pain, and more than a third said the episode hampered their ability to work or take part in social activities.
  • Respondents with chronic kidney and cardiovascular disease reported greater disruption.

Growing Public-Health Impact:

  • India's population aged 60 and above is projected to more than double from 153 million to 347 million by 2050.
  • The burden of age-linked infections like shingles is expected to rise sharply.

Prevention Efforts:

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

  • GSK has launched its shingles vaccine, Shingrix, in India in April 2023 for adults aged 50 and above.
  • The recombinant, non-live vaccine offers more than 90% efficacy and provides at least 10 years of protection, making it suitable even for immunocompromised adults.
  • GSK's focus on shingles aligns with its broader adult-vaccination strategy and efforts to integrate preventive care into India's health system.

Recommendations:

  • Doctor-initiated conversations remain the strongest driver of preventive action: respondents who heard about shingles from a healthcare professional were far more likely to consider vaccination.
  • Regular, informed conversations between patients and doctors are essential to address the growing need for preventive care among ageing adults.

Investor Takeaway

Investors should be aware of the growing healthcare needs in India's aging population.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.